Drug Trial Radar · NCT01156571
A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
Last checked: Nov 20, 2026Latest source record: Feb 4, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
11,145
Actual
Start
Sep 2010
Primary completion
Dec 2012
Study completion Dec 2012
Sponsor
- Lead sponsor
- The Medicines CompanyIndustry
- Sponsor type
- Industry
- First posted
- Jul 5, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is designed to compare the efficacy and safety profile of cangrelor to standard of care in patients require percutaneous coronary intervention (PCI).
Conditions
- Atherosclerosis
- Percutaneous Coronary Intervention
- Acute Coronary Syndrome
Interventions
cangrelor P2Y12 (platelet) inhibitorDrug
Clopidogrel - 300 or 600 mg (study arm)Drug
Over encapsulated tablets.
Clopidogrel 600 mg post cangrelorDrug
over-encapsulated clopidogrel (600 mg)
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Composite Incidence of All-cause Mortality, Myocardial Infarction (MI), Ischemia-driven Revascularization (IDR) and Stent Thrombosis (ST)Time frame: 48 hours after randomization
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Anderson Area Medical Center
Anderson, South Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.